Gut bacteria boosts cancer treatment? new trial tests Probio-M9 in rectal cancer
Disease control
Recruiting now
This study tests whether adding a probiotic called Probio-M9 to standard chemoradiation and immunotherapy (tislelizumab) can help shrink rectal tumors before surgery. About 50 adults with locally advanced rectal cancer will be randomly assigned to receive the probiotic or a place…
Phase: PHASE2 • Sponsor: Seventh Medical Center of PLA General Hospital • Aim: Disease control
Last updated May 12, 2026 13:43 UTC